 RALEIGH, N.C., Nov. 11, 2020 GLOBE NEWSWIRE -- BioDelivery Sciences International, Inc. NASDAQ: BDSI, a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Chief Financial Officer, will participate in the virtual Southwest IDEAS Investor Conference on November 18, 2020. BDSIs presentation will be webcasted and is scheduled to be available at 7:00 am CST on November 18. The presentation can be accessed through the Southwest IDEAS conference portal for registered participants, in the investor relations section of the Companys website: and on the IDEAS conference website: 